Summary
- Current Price
- As of today, KLRA price is $11.61, up +16.10% on
- Current Price All-Time High
- KLRA price is currently -58.87% below its historical high of $28.23 set on
- Market Cap
- KLRA current market cap is $2B
- Revenue
- KLRA current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for KLRA is on
Profile
| Metric | Value |
|---|---|
| Full Name | Kailera Therapeutics, Inc. |
| Ticker | NASDAQ: KLRA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | kailera.com |
| Employees | 145 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $11.61 | |
| Price, 1D Change | +16.10% | |
| $2B | ||
| - | ||
| - | ||
| 1.08 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.76 | ||
| EPS, 1Y Change | +32.20% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.76 | ||
| EPS Estimate | -$4.10 | N/A |
| EPS Est. Change | -132.71% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $11.61 | |
| Price Target | $41.00 | - |
| Price Tgt. Change | +253.14% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$2.60 | - | |
| - | -$1.76 | - | |
| -$4.10 | N/A | -132.71% | |
| -$4.30 | N/A | -144.04% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $11.61 | |
| $18.67 | ||
| $15.05 | ||
| - | ||
| $14.39 | ||
| -$1.29 | ||
| 1.08 | ||
| $1.03 | ||
| 43.05 | ||
| 101.93% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$1.76 | ||
| -$310.00K | ||
| - | ||
| -$158.34M | ||
| - | ||
| -$148.96M | ||
| - | ||
| -$158.03M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.02 | ||
| 12.01 | ||
| 12.01 | ||
| - | ||
| - | ||
| 15.37 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 1.35 | ||
| -2.91 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| -$356.46M | ||
| $546.06M | ||
| $692.41M | ||
| $557.54M | ||
| $56.51M | ||
| $46.41M | ||
| $10.75M | ||
| $1.04M | ||
| $7.53M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $148.96M | ||
| $158.03M | ||
| $310.00K | ||
| $49.23M | ||
| $310.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$120.21M | ||
| -$492.60M | ||
| $598.66M | ||
| $2.09M | ||
| -$122.30M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Leerink Partners | ||
| JP Morgan | ||
| Jefferies | ||
| Evercore ISI Group |
Analyst sentiment
Institutional ownership
Screeners with KLRA
FAQ
- What is the ticker symbol for Kailera Therapeutics, Inc.?
- The ticker symbol for Kailera Therapeutics, Inc. is NASDAQ:KLRA
- Does Kailera Therapeutics, Inc. pay dividends?
- No, Kailera Therapeutics, Inc. does not pay dividends
- What sector is Kailera Therapeutics, Inc. in?
- Kailera Therapeutics, Inc. is in the Healthcare sector
- What industry is Kailera Therapeutics, Inc. in?
- Kailera Therapeutics, Inc. is in the Biotechnology industry
- What country is Kailera Therapeutics, Inc. based in?
- Kailera Therapeutics, Inc. is headquartered in United States
- When did Kailera Therapeutics, Inc. go public?
- Kailera Therapeutics, Inc. initial public offering (IPO) was on April 17, 2026
- Is Kailera Therapeutics, Inc. in the S&P 500?
- No, Kailera Therapeutics, Inc. is not included in the S&P 500 index
- Is Kailera Therapeutics, Inc. in the NASDAQ 100?
- No, Kailera Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Kailera Therapeutics, Inc. in the Dow Jones?
- No, Kailera Therapeutics, Inc. is not included in the Dow Jones index
- When was Kailera Therapeutics, Inc. last earnings report?
- Kailera Therapeutics, Inc.'s most recent earnings report was on August 12, 2026
- When does Kailera Therapeutics, Inc. report earnings?
- The next expected earnings date for Kailera Therapeutics, Inc. is November 4, 2026
Data Sources & References
- KLRA Official Website www.kailera.com
- KLRA Profile on Yahoo Finance finance.yahoo.com/quote/KLRA
- KLRA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/klra